About Swedish Cancer Institute Research

Clinical cancer research is a vital component of the Swedish Cancer Institute. The Swedish Cancer Institute’s research division works closely with other medical and research organizations, as well as pharmaceutical and biotech companies. It offers clinical trials through a wide variety of organizations, such as the Southwest Oncology Group (SWOG); the National Cancer Institute’s Cancer Trials Support Unit (CTSU); the American College of Surgeons Oncology Group (ACOSOG); the Radiation Therapy Oncology Group (RTOG); the National Surgical Adjuvant Breast and Bowel Project (NSABP); and Swedish’s own physician-initiated research.

Swedish Cancer Institute Leads the Way

Swedish Cancer Institute (SCI) physician investigators and research partners are at the leading edge of the clinical trials stage of the research process. Swedish is one of the leading clinical trial sites in the western United States and is actively involved in hundreds of ongoing clinical trials involving most types of cancer. SCI is often the only site in the Pacific Northwest—and sometimes the first in the world—to participate in many clinical trials.

At SCI, our studies:

• Find new treatments and/or more effective combinations of treatments
• Identify new methods of detecting cancer in its earliest stages
• Discover new ways to improve the quality of life of cancer patients
• Test new approaches to preventing cancer